Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)2 Weekly Intra-articular Hyaluronan Knee Injections, Given 1 wk. Apart, of HYMOVIS Combined With Physical Exercise Program (PEP) Compared to PEP Alone, in Relatively Young, Active Population of Subjects With Patellofemoral Osteoarthritis (PFOA) and/or Tibiofemoral Osteoarthritis (TFOA)
Not Applicable
Completed
- Conditions
- Knee OsteoarthritisOsteoarthritis, KneePatellofemoral Osteoarthritis
- First Posted Date
- 2017-09-13
- Last Posted Date
- 2020-07-21
- Lead Sponsor
- Fidia Pharma USA Inc.
- Target Recruit Count
- 148
- Registration Number
- NCT03281837
- Locations
- 🇺🇸
Tucson Orthopaedic Institute Research Center, Tucson, Arizona, United States
🇺🇸CORE Orthopaedic Medical Center, Encinitas, California, United States
🇺🇸Kerlan-Jobe Orthopaedic Clinic, Los Angeles, California, United States
News
No news found